No Matches Found
No Matches Found
No Matches Found
biote Corp. Hits 52-Week Low of $1.73 Amid 72.2% Decline
biote Corp., a microcap hospital industry company, has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. The company faces financial challenges, including a negative book value, declining net profit, and low sales, raising concerns about its long-term viability.
biote Corp. Hits New 52-Week Low at $1.86 Amidst Major Decline
biote Corp., a microcap in the hospital sector, has reached a 52-week low, reflecting a challenging year with a significant stock price decline. The company faces financial difficulties, including a negative book value, declining net profit, and poor debt management, while consistently underperforming compared to the S&P 500.
Biote Corp. Stock Plummets to New 52-Week Low of $2.65
biote Corp., a microcap in the hospital sector, has hit a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company faces financial challenges, including negative book value and a concerning debt-to-equity ratio, alongside a notable drop in net profit and inventory turnover.
Is biote Corp. technically bullish or bearish?
As of August 7, 2025, biote Corp. is in a bearish trend, indicated by negative signals from MACD, moving averages, and Bollinger Bands, with a year-to-date return of -45.47% compared to the S&P 500's 12.22%.
Is biote Corp. overvalued or undervalued?
As of June 22, 2022, Biote Corp. is considered a risky investment but appears undervalued with a low P/E ratio of 5.23, suggesting potential growth despite recent struggles and a year-to-date return of -35.11%.
Is biote Corp. technically bullish or bearish?
As of May 8, 2024, Biote Corp. shows a moderate bullish trend with mixed signals: weekly indicators are mildly bullish while monthly indicators remain bearish, suggesting short-term strength but potential longer-term weakness.
What does biote Corp. do?
biote Corp. is a micro-cap company in the hospital industry, reporting net sales of $49 million and a net profit of $16 million as of March 2025. Key financial metrics include a P/E ratio of 5.00 and a market cap of $156.74 million.
How big is biote Corp.?
As of Jun 18, biote Corp. has a market capitalization of 156.74 million, with net sales of 199.37 million and a net profit of 21.51 million over the latest four quarters. The balance sheet shows shareholder's funds of -105.93 million and total assets of 122.37 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
